Serum Potassium and Cardiovascular Outcomes: The Highs and the Lows.
作者信息
Toto Robert D
机构信息
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
出版信息
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):220-221. doi: 10.2215/CJN.00030117. Epub 2017 Jan 31.
Abstract
摘要
相似文献
1
Serum Potassium and Cardiovascular Outcomes: The Highs and the Lows.
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):220-221. doi: 10.2215/CJN.00030117. Epub 2017 Jan 31.
2
Imagery of different sensory modalities: hypnotizability and body sway.
Exp Brain Res. 2007 May;179(2):147-54. doi: 10.1007/s00221-006-0776-0. Epub 2006 Nov 14.
3
Modulation of the heartbeat evoked cortical potential by hypnotizability and hypnosis.
Psychophysiology. 2023 Sep;60(9):e14309. doi: 10.1111/psyp.14309. Epub 2023 Apr 18.
4
Attention or instruction: Do sustained attentional abilities really differ between high and low hypnotisable persons?
Psychol Res. 2018 Jul;82(4):700-707. doi: 10.1007/s00426-017-0850-1. Epub 2017 Mar 7.
5
Relaxation as a cognitive task.
Arch Ital Biol. 2005 Feb;143(1):1-12.
6
Hypnotizability and sensorimotor integration: an Italian Space Agency project.
Int J Clin Exp Hypn. 2010 Jan;58(1):122-35. doi: 10.1080/00207140903316169.
7
Manipulation of attention in highly and low hypnotizable individuals: a study on verbal priming.
Arch Ital Biol. 2008 Mar;146(1):21-33.
8
Paradoxical experience of hypnotic analgesia in low hypnotizable fibromyalgic patients.
Arch Ital Biol. 2008 Jun;146(2):75-82.
9
The neurophenomenology of neutral hypnosis.
Cortex. 2013 Feb;49(2):375-85. doi: 10.1016/j.cortex.2012.04.001. Epub 2012 Apr 11.
10
Is Hypnotic Induction Necessary to Experience Hypnosis and Responsible for Changes in Brain Activity?
Brain Sci. 2023 May 29;13(6):875. doi: 10.3390/brainsci13060875.
引用本文的文献
1
Proton pump inhibitors and cardiovascular risk: a critical review.
Future Cardiol. 2024;20(14):779-794. doi: 10.1080/14796678.2024.2412910. Epub 2024 Oct 28.
2
Effects of hyperkalaemia and non-adherence to renin-angiotensin-aldosterone system inhibitor therapy in patients with heart failure in Italy: a propensity-matched study.
Eur J Heart Fail. 2020 Nov;22(11):2049-2055. doi: 10.1002/ejhf.2024. Epub 2020 Oct 27.
3
Hyperkalemia: pathophysiology, risk factors and consequences.
Nephrol Dial Transplant. 2019 Dec 1;34(Suppl 3):iii2-iii11. doi: 10.1093/ndt/gfz206.
4
Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease.
Kidney Int Rep. 2017 Jul 17;2(6):1122-1131. doi: 10.1016/j.ekir.2017.07.001. eCollection 2017 Nov.
Zotero 插件